Transvenous retrieval of chronically implanted dual-chamber leadless pacemakers was successful in 100% of devices (18/18) without complications at a median of 1.9 years postimplant.
Does transvenous retrieval safely and effectively remove chronically implanted dual-chamber leadless pacemakers in an ovine model?
Transvenous retrieval of chronically implanted dual-chamber leadless pacemakers is safe and highly successful in a preclinical ovine model at nearly 2 years post-implant.
BACKGROUND: The clinical utilization of leadless pacemakers (LPs) as an alternative to traditional transvenous pacemakers is likely to increase with the advent of dual-chamber LP systems. Since device retrieval to allow LP upgrade or replacement will become an important capability, the first such dual-chamber, helix-fixation LP system (Aveir DR; Abbott, Abbott Park, IL) was specifically designed to allow catheter-based retrieval. In this study, the preclinical performance and safety of retrieving chronically implanted dual-chamber LPs was evaluated. METHODS: Atrial and ventricular LPs were implanted in the right atrial appendage and right ventricular apex of 9 healthy ovine subjects. After ≈2 years, the LPs were retrieved using a dedicated transvenous retrieval catheter (Aveir Retrieval Catheter; Abbott) by snaring, docking, and unscrewing from the myocardium. Comprehensive necropsy/histopathology studies were conducted to evaluate device- and procedure-related outcomes. RESULTS: At a median of 1.9 years postimplant (range, 1.8-2.6), all 18 of 18 (100%) LPs were retrieved from 9 ovine subjects without complications. The median retrieval procedure duration for both LPs, from first-catheter-in to last-catheter-out, was 13.3 minutes (range, 2.5-36.4). Postretrieval, all right atrial, and right ventricular implant sites demonstrated minimal tissue disruption, with intact fibrous tissue limited to the distal device body. No significant device-related trauma, perforation, pericardial effusion, right heart or tricuspid valve injury, or chronic pulmonary thromboembolism were observed at necropsy. CONCLUSIONS: This preclinical study demonstrated the safe and effective retrieval of chronically implanted, helix-fixation, dual-chamber LP systems, paving the way for clinical studies of LP retrieval.
Banker et al. (Thu,) conducted a other in Healthy ovine subjects (n=9). Transvenous retrieval of dual-chamber leadless pacemakers was evaluated on Successful device retrieval without complications. Transvenous retrieval of chronically implanted dual-chamber leadless pacemakers was successful in 100% of devices (18/18) without complications at a median of 1.9 years postimplant.